longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Evexta Bio and Roche plan Phase Ib trial of rupitasertib with giredestrant

WorldPharmaceuticals
Aug 5, 2026 at 10:34 AM

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

Login to unlock221characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Dec 17, 2025 at 09:07 PMTrade tensions between Switzerland and the United States have further eased, with Novartis and Roche expected to reach a…
  • Oct 17, 2025 at 02:59 AMInnovative drugs make another breakthrough overseas! HANSOH PHARMA signs a licensing agreement with Roche for colorectal…
  • Aug 25, 2025 at 07:47 PMTrump threatens to take real action on U.S. drug prices, claiming to reduce drug prices by 1500%, causing a drop in the …
  • Jul 25, 2025 at 12:39 AMPharmaceutical Giants: It's Simple to "Cut U.S. Drug Prices in Half"

Related Stocks

Roche

Roche

USRHHBY

-0.52%

ROCHE HOLDINGS AG

ROCHE HOLDINGS AG

USRHHVF

LongbridgeAI